medcity ltd
medcity ltd Company Information
Company Number
08792892
Next Accounts
Dec 2025
Industry
Research and experimental development on biotechnology
Shareholders
-
Group Structure
View All
Contact
Registered Address
169 (london & partners), union street, london, SE1 0LL
Website
www.medcitylondon.commedcity ltd Estimated Valuation
Pomanda estimates the enterprise value of MEDCITY LTD at £0 based on a Turnover of £0 and 1.5x industry multiple (adjusted for size and gross margin).
medcity ltd Estimated Valuation
Pomanda estimates the enterprise value of MEDCITY LTD at £0 based on an EBITDA of £-713.7k and a 5.36x industry multiple (adjusted for size and gross margin).
medcity ltd Estimated Valuation
Pomanda estimates the enterprise value of MEDCITY LTD at £0 based on Net Assets of £0 and 1.84x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medcity Ltd Overview
Medcity Ltd is a live company located in london, SE1 0LL with a Companies House number of 08792892. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in November 2013, it's largest shareholder is unknown. Medcity Ltd is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medcity Ltd Health Check
There is insufficient data available to calculate a health check for Medcity Ltd. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Medcity Ltd
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Medcity Ltd
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Medcity Ltd
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Medcity Ltd
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Medcity Ltd
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Medcity Ltd
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Medcity Ltd
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Medcity Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Medcity Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Medcity Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Medcity Ltd
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Medcity Ltd
- - Industry AVG
MEDCITY LTD financials
Medcity Ltd's latest turnover from March 2024 is estimated at 0 and the company has net assets of 0. According to their latest financial statements, we estimate that Medcity Ltd has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | ||||||||||
| Tax | ||||||||||
| Profit After Tax | ||||||||||
| Dividends Paid | ||||||||||
| Retained Profit | ||||||||||
| Employee Costs | ||||||||||
| Number Of Employees | 12 | 10 | 10 | 9 | 9 | 9 | 9 | 7 | ||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 5,514 | 5,959 | 4,247 | 5,409 | 270 | 135 | 366 | 871 | 1,356 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 5,514 | 5,959 | 4,247 | 5,409 | 270 | 135 | 366 | 871 | 1,356 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 882,475 | 215,429 | 57,583 | 320,079 | 225,617 | 23,478 | 0 | 0 | 21,118 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 36,004 | 0 | 0 | 0 | 0 | 277,000 | 0 |
| Cash | 0 | 0 | 855,584 | 517,757 | 165,157 | 205,494 | 176,751 | 70,028 | 18,765 | 282,909 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 0 | 882,475 | 1,071,013 | 611,344 | 485,236 | 431,111 | 200,229 | 70,028 | 295,765 | 304,027 |
| total assets | 0 | 887,989 | 1,076,972 | 615,591 | 490,645 | 431,381 | 200,364 | 70,394 | 296,636 | 305,383 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 174,257 | 162,328 | 175,009 | 0 | 0 | 0 | 0 | 0 | 326,977 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 259,403 | 117,905 | 329,516 | 270,412 | 109,203 | 17,336 | 189,749 | 0 |
| total current liabilities | 0 | 174,257 | 421,731 | 292,914 | 329,516 | 270,412 | 109,203 | 17,336 | 189,749 | 326,977 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 174,257 | 421,731 | 292,914 | 329,516 | 270,412 | 109,203 | 17,336 | 189,749 | 326,977 |
| net assets | 0 | 713,732 | 655,241 | 322,677 | 161,129 | 160,969 | 91,161 | 53,058 | 106,887 | -21,594 |
| total shareholders funds | 0 | 713,732 | 655,241 | 322,677 | 161,129 | 160,969 | 91,161 | 53,058 | 106,887 | -21,594 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | 3,590 | 4,217 | 3,577 | 2,771 | 269 | 231 | 909 | 774 | 678 | |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Tax | ||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -882,475 | 667,046 | 121,842 | -226,492 | 94,462 | 202,139 | 23,478 | -277,000 | 255,882 | 21,118 |
| Creditors | -174,257 | 11,929 | -12,681 | 175,009 | 0 | 0 | 0 | 0 | -326,977 | 326,977 |
| Accruals and Deferred Income | 0 | -259,403 | 141,498 | -211,611 | 59,104 | 161,209 | 91,867 | -172,413 | 189,749 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | ||||||||||
| cash and cash equivalents | ||||||||||
| cash | 0 | -855,584 | 337,827 | 352,600 | -40,337 | 28,743 | 106,723 | 51,263 | -264,144 | 282,909 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | -855,584 | 337,827 | 352,600 | -40,337 | 28,743 | 106,723 | 51,263 | -264,144 | 282,909 |
medcity ltd Credit Report and Business Information
Medcity Ltd Competitor Analysis
Perform a competitor analysis for medcity ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other established companies, companies in SE1 area or any other competitors across 12 key performance metrics.
medcity ltd Ownership
MEDCITY LTD group structure
Medcity Ltd has no subsidiary companies.
Ultimate parent company
MEDCITY LTD
08792892
medcity ltd directors
Medcity Ltd currently has 4 directors. The longest serving directors include Professor Jonathan Weber (Oct 2017) and Professor Richard Trembath (Sep 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Professor Jonathan Weber | 70 years | Oct 2017 | - | Director | |
| Professor Richard Trembath | 68 years | Sep 2020 | - | Director | |
| Ms Joanne Pisani | England | 60 years | Jan 2021 | - | Director |
| Professor Sir Mark Caulfield | 64 years | Nov 2022 | - | Director |
P&L
March 2024turnover
0
-100%
operating profit
-713.7k
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
0
-1%
total assets
0
-1%
cash
0
0%
net assets
Total assets minus all liabilities
medcity ltd company details
company number
08792892
Type
Private Ltd By Guarantee w/o Share Cap
industry
72110 - Research and experimental development on biotechnology
incorporation date
November 2013
age
12
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
169 (london & partners), union street, london, SE1 0LL
Bank
-
Legal Advisor
-
medcity ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to medcity ltd.
medcity ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDCITY LTD. This can take several minutes, an email will notify you when this has completed.
medcity ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
